Trial Profile
Randomized, monocentric trial on sintoms, adherence,toxicity of alternate antiretrovirale regimen.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 27 Jul 2011 New trial record